Vinati Organics reported a 27% quarter-on-quarter rise in profit after tax to ₹137 crore for the quarter ended March 31, 2026, driven by operational improvements and a strong customer-centric approach. The company remains debt-free and has a treasury of approximately ₹190 crore as of March 31, 2026. The Board of Directors has recommended a dividend of ₹8.50 per equity share of face value of ₹1 for the financial year 2025-26, subject to shareholder approval.

On a standalone basis, net income, including other income, increased by 17% to ₹631 crore in Q4FY26 from ₹538 crore in the previous quarter. EBITDA grew by 20% to ₹203 crore compared to ₹169 crore in Q3FY26. For the full year, net income remained stable at ₹2,281 crore, while EBITDA grew by 17% to ₹741 crore and PAT increased by 18% to ₹488 crore compared to the previous year.

On a consolidated basis, net income rose 16% to ₹624 crore in Q4FY26, with EBITDA growing 15% to ₹191 crore and PAT increasing 23% to ₹123 crore. For the full year, consolidated net income was stable at ₹2,280 crore, EBITDA grew 13% to ₹707 crore, and PAT increased 9% to ₹444 crore.

Operational Performance

The company's global market share in ATBS remained robust, with expectations of approximately 15% to 20% volume growth in FY 2027. The butyl phenols segment delivered steady performance, while IB and HP-MTBE are expected to achieve double-digit growth in FY 2027. The customized products segment recorded 10% year-on-year growth, and the antioxidants business delivered 15% revenue growth in FY 2026. IBB volume declined by approximately 20% compared to FY 2025 due to raw material unavailability, which has since been resolved.

Financial Highlights

Capital Expenditure and Outlook

The company incurred approximately ₹270 crore in capex in FY 2026, including investments in its subsidiary VOPL for capacity expansion. It has earmarked approximately ₹200 crore to ₹250 crore of capex for FY 2027. Management targets approximately 15% volume growth at the company level in FY 2027 and maintains a long-term EBITDA margin outlook of 26% to 27%. The R&D team is working on new products in niche segments such as fragrance, personal care, and food additives, with revenue contributions expected from FY28.

Vinati Organics Limited has scheduled a one-on-one meeting with Aditya Birla Sun Life AMC on June 3, 2026. The meeting will be held in person at the company's Corporate Office in Mumbai between 04:00 PM and 05:00 PM. This interaction is part of the company's ongoing engagement with analysts and institutional investors.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Vinati Organics clarified that no unpublished or price-sensitive information will be disclosed or discussed during the aforesaid meeting. The company noted that the schedule is subject to change due to exigencies on the part of the investors or the company.

Meeting Schedule

The filing was submitted by Milind Wagh, Senior Vice President – Company Secretary, on behalf of Vinati Organics Limited.